Thursday, October 19, 2017 4:03:49 PM
SOURCE: https://www.dailymarijuanaobserver.com/single-post/2017/10/19/CRBP-Is-Corbus-Pharmaceuticals-a-Cannabis-Stock-Kind-of
Shares of Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP) are ripping today in reaction to the company's announcement of positive phase 2 trial results for its drug aiming to treat "rare, chronic, serious inflammatory and fibrotic diseases." Since this drug interacts with the body's natural endocannabinoid system, many investors are asking - is Corbus Pharmaceuticals a cannabis stock? Kind of.
Corbus' drug, called "anabasum," is a "novel synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes." As a endocannabinoid-mimetic drug, it binds with the body's cannabinoid receptors in order to take effect. By binding to the CB2 receptors on immune cells and fibroblasts, anabasum is far more effective in treating the above indications than the placebo.
In addition to being highly effective, "anabasum was well tolerated with no severe or serious side effects associated with the drug. No subjects dropped out." This is a great sign given how terrible the side effects of some drugs can be.
Corbus Pharmaceuticals Upside
According to the Cystic Fibrosis Foundation Patient Registry, in the United States, more than 30,000 people are living with cystic fibrosis (more than 70,000 worldwide). Additionally, approximately 1,000 new cases of CF are diagnosed each year.
The global cystic fibrosis therapeutics market is expected to reach USD 13.9 billion by 2025, according to a new report by Grand View Research. If this drug makes it through to FDA approval, "it could easily leap to $1 billion in annual sales," according to estimates from the Motley Fool.
Recent CRBP News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2024 08:52:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 08:48:47 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 08:45:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/20/2024 12:15:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 08:42:25 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2024 08:38:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 12:15:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/18/2024 09:58:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2024 01:21:16 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/14/2024 09:25:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/03/2024 08:32:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/03/2024 08:30:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/03/2024 08:29:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/03/2024 08:28:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/03/2024 08:26:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 11:08:54 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/31/2024 08:39:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/20/2024 09:00:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/20/2024 08:59:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/20/2024 08:58:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/20/2024 08:54:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/20/2024 08:53:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 08:30:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 12:00:13 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/08/2024 08:03:35 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM